The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.

"Currently, there is no therapeutic cure for HIV," Sheryl Zwerski, who holds a Doctor of Nursing Practice and directs the Prevention Sciences Program at the National Institute of Allergy and ...

A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...

A new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the ...

Gilead Sciences (GILD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Courtney ...

FOX 5 spoke exclusively with a participant in a study for a new injectable drug to prevent HIV. Emory University medical ...

One study revealed that injection of the medication lenacapavir every six months could greatly reduce the risk for HIV ...

The incidence of HIV is lower with receipt of twice-yearly subcutaneous lenacapavir compared with daily oral emtricitabine-tenofovir disoproxil fumarate.

Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates, mostly in ...

Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons,” published in the November 2024 issue of Infectious ...